ConductScience.org, home

Paper1979245

Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.

Shalinsky DR and 2 others. Cancer Res, 1990. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Papers, record 1979245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1979245

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
PubMed
Journal
Cancer Res
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2018-11-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shalinsky DRD R
2Andreeff MM
3Howell SBS B

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
DipyridamoleMajor topic
Drug ResistanceMajor topic
ATP Binding Cassette Transporter, Subfamily B, Member 1
Cell Survival
Colchicine
Drug Synergism
Etoposide
Humans
In Vitro Techniques
Membrane Glycoproteins
Neoplasm Proteins
Verapamil
Vinblastine

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 09290-11NCI NIH HHSUnited StatesPubMedPubMed
CA 23100NCI NIH HHSUnited StatesP30CA023100PubMed and NIHNIH RePORTER
CA 35309NCI NIH HHSUnited StatesR01CA035309PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
36273882Effect of Dipyridamole on Membrane Energization and Energy Transfer in Chromatophores of Rba. sphaeroides.Biochemistry (Mosc)2022https://conductscience.org/library/papers/36273882PubMed
28510131Generation of radical form of dipyridamole at illumination of photosynthetic reaction centers of Rb. sphaeroides.Dokl Biochem Biophys2017https://conductscience.org/library/papers/28510131PubMed
10696508Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain.Cell Mol Neurobiol2000https://conductscience.org/library/papers/10696508PubMed
8611395Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.Br J Cancer1996https://conductscience.org/library/papers/8611395PubMed
8609155Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo.J Cancer Res Clin Oncol1996https://conductscience.org/library/papers/8609155PubMed
8431967Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8431967PubMed
8094975Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.Br J Cancer1993https://conductscience.org/library/papers/8094975PubMed
8094005Regulation of initial vinblastine influx by P-glycoprotein.Br J Cancer1993https://conductscience.org/library/papers/8094005PubMed
7767952Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7767952PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed
7533669Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7533669PubMed
1680368Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.Br J Cancer1991https://conductscience.org/library/papers/1680368PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
CMAS55907PubTator's text mininghttps://conductscience.org/library/genes/55907NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1979245

GET https://conductscience.org/api/papers/v1/1979245/authors